270
Participants
Start Date
March 31, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
ET-26HCl 0.8mg/kg group
The initial dose was 0.8 mg/kg administered as a single IV infusion over a period of 1 minute ±5 seconds. If needed, up to 50% of the starting dose was increased (30-seconds ± 5-seconds bolus)
Etomidate Injectable Product 0.3mg/kg group
The initial dose was 0.3 mg/kg administered as a single IV infusion over a period of 1 minute ±5 seconds. If needed, up to 50% of the starting dose was increased (30-seconds ± 5-seconds bolus)
Peking University First Hospital, Beijing
Shenzhen People's Hospital, Shenzhen
West China Hospital of Sichuan University, Chengdu
Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital, Chengdu
Guangyuan First People's Hospital, Guangyuan
Yibin Second People's Hospital, Yibin
Lead Sponsor
Ahon Pharmaceutical Co., Ltd.
OTHER